Establishment of a novel biomarker of skeletal and cardiac muscle diseases

Establishment of a novel biomarker of skeletal and cardiac muscle diseases - A novel biomarker of skeletal and cardiac muscle diseases

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032873

Enrollment

290

Registered

2018-06-05

Start date

2016-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal and cardiac muscle diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suffering skeletal and cardiac muscle diseases, and normal control subjects

Exclusion criteria

Exclusion criteria: No severe medical conditions, including stroke, diabetes, chronic liver disease, and chronic kidney diease

Design outcomes

Primary

Measure	Time frame
Definition of a cutoff values of a novel biomarker in an optimal ELISA	—

Secondary

Measure	Time frame
Characterization of skeletal and cardiac muscle diseases by the novel biomarker using the optimal ELISA	—

Countries

Japan

Contacts

Public ContactYutaka Ohsawa

Kawasaki Medical School Neurology

yosawa@med.kawasaki-m.ac.jp+81-86-462-1111

Outcome results